Literature DB >> 1239828

Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases.

N Reichert, U Seligsohn, B Ramot.   

Abstract

Twenty two patients (12 males and 10 females) from all over Israel fulfilled the criteria for establishing the diagnosis of Glanzmann's thrombasthenia. All have been observed to have a servere bleeding tendency since infancy or early childhood. In 8 out of 10 adult patients (7 females and 3 males) the bleeding manifestations have persisted over the years. In 2 adult patients major surgery was performed under platelet transfusions which appeared to prevent excessive bleeding. Pedigree analysis was possible for 21 patients who belong to 13 unrelated kindreds. Twelve kindreds are Jewish and one is Arab. Eleven of the 12 Jewish kindreds belong to the Iraqi Jewish community. Analysis of 16 sibships disclosed a corrected segregation ratio of 0.2, which is compatible with an autosomal recessive mode of inheritance. No bleeding manifestation whatsoever were observed in 30 obligatory carriers of thrombasthania, and the haemostatic functions tested in 12 of them were entirely normal.

Entities:  

Mesh:

Year:  1975        PMID: 1239828

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


  8 in total

1.  Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice.

Authors:  Vaishali V Inamdar; John C Kostyak; Rachit Badolia; Carol A Dangelmaier; Bhanu Kanth Manne; Akruti Patel; Soochong Kim; Satya P Kunapuli
Journal:  Thromb Haemost       Date:  2019-06-21       Impact factor: 5.249

2.  The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.

Authors:  Giovanni Di Minno; Rainer B Zotz; Roseline d'Oiron; Niels Bindslev; Matteo Nicola Dario Di Minno; Man-Chiu Poon
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

3.  The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.

Authors:  P J Newman; U Seligsohn; S Lyman; B S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins.

Authors:  D R Phillips; P P Agin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

5.  αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.

Authors:  Lorena Buitrago; Augusto Rendon; Yupu Liang; Ilenia Simeoni; Ana Negri; Marta Filizola; Willem H Ouwehand; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

6.  Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center.

Authors:  Ganesh Kasinathan; Jameela Sathar
Journal:  Blood Res       Date:  2021-12-31

Review 7.  Genetics of equine bleeding disorders.

Authors:  Anna R Dahlgren; Fern Tablin; Carrie J Finno
Journal:  Equine Vet J       Date:  2020-06-23       Impact factor: 2.888

8.  GLANZMANN's THROMBASTHENIA-SPECTRUM OF CLINICAL PRESENTATION ON SAUDI PATIENTS IN THE EASTERN PROVINCE.

Authors:  S K Ai-Barghouthi; A Ai-Othman; A Lardhi
Journal:  J Family Community Med       Date:  1997-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.